The Chamber of Commerce’s lawsuit is the first test of a barrage of lawsuits fro...
The FDA announced its intention to start regulating tests developed in laborator...
In a highly unusual move, Unitaid has publicly criticized Johnson & Johnson over...
A handful of the largest purveyors of generic medicines have made only halting p...
Prescription medicines purchased in the U.S. under a controversial government di...
The WHO has recommended dropping a component of many flu vaccines because the vi...
The deadline for drugmakers to sign agreements to negotiate with Medicare on pri...
In 2021, women paid about 20% more for out-of-pocket medical expenses than men —...
Rapid, complex, and technically sound data analysis is insufficient — and someti...
The shrinking of Taysha Gene Therapies has left many families, who funded the ea...
The CEO of Mass General Brigham discussed the system’s split with Dana-Farber Ca...
At the industry crossroads of healthcare and pharmaceuticals at the Life Science...
Amicus Therapeutics has received approval from the US FDA for the two-component ...
HitGen and the Structural Genomics Consortium entered a collaboration to discove...
Deka Biosciences has secured funding of $20m in a Series B2 financing round to a...
The FDA has set 31 March 2024 as the PDUFA action date for reviewing odronextama...
